Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Zenas BioPharma, Inc. (ZBIO) Institutional Ownership & Insider Trading

145 institutions reported holding Zenas BioPharma, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 25 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ZBIOZenas BioPharma, Inc.Follow ZBIO — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
1.8B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
18 Nov, in 25 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

145 institutions held 94.0% of the shares. Across filers that reported both quarters, shares held changed +6.3%.

Increased+59New+24Decreased-35Closed-20

Largest moves, shares (millions)

T. Rowe Price Associates+0.9MBank of America+0.8MBlackRock+0.6MSilverarc Capital Management-0.6MGreat Point Partners-0.5MJefferies Financial Group-0.2M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
+0.0Sep 24+3.1Dec 24+0.8Mar 25+1.6Jun 25+0.7Sep 25+6.5Dec 25+13.6Mar 26+3.6Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 2614561+6.3%59243520
Mar 2613955+34.0%56441626
Dec 2511742+18.6%3640227
Sep 257835+2.1%2213197
Jun 257234+4.8%3210104
Mar 256732+2.7%1312198
Dec 246432+13.6%1329613
Sep 244325—————

Zenas BioPharma, Inc. — questions

Who owns Zenas BioPharma, Inc. stock?
145 institutions reported Zenas BioPharma, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: FMR LLC (14.6%), SR One Capital Management, LP (7.7%), NEA Management Company, LLC (6.2%).
Are Zenas BioPharma, Inc. insiders buying or selling?
25 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Zenas BioPharma, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.